Sanofi’s MenQuadfi approved for EU infants

RegulatoryapprovedMenQuadfiPositive

AI Analysis

Summary

The European Commission has approved Sanofi's MenQuadfi for use in infants, expanding the meningococcal vaccine's indication to protect the youngest children.

Outcome Details

European Commission approved MenQuadfi for use in infants, expanding indication to youngest children

Importance:7/10

Sentiment:

0.80

regulatory approvalEuropepediatricvaccinelabel expansion

Related Companies

$SNY

Read the original article

Published by PharmaTimes on August 4, 2026 11:18 AM

Read Original